The baby formula controversy at Abbott Laboratories (ABT) got exacerbated yet again after the Food and Drug Administration (FDA) revealed that it had initiated an investigation linked to the death of another infant who was given formula made by Abbott. The infant, who died in January, was found with Cronobacter bacteria. However, the FDA was notified about the mishap on June 10. Furthermore, four babies who were reported ill after receiving Abbott formula also had cronobacter infections.  Turn of Events In February 2022, Abbott recalled formula, including Similac, after four babies became ill following the consumption of its products, of which two infants died.
https://www.tipranks.com/news/is-there-any-end-in-sight-to-the-abbott-baby-formula-controversy?utm_source=advfn.com&utm_medium=referral
Abbott Laboratories (NYSE:ABT)
Graphique Historique de l'Action
De Juil 2022 à Août 2022 Plus de graphiques de la Bourse Abbott Laboratories
Abbott Laboratories (NYSE:ABT)
Graphique Historique de l'Action
De Août 2021 à Août 2022 Plus de graphiques de la Bourse Abbott Laboratories